OA12648A - Novel crystalline polymorphic forms of lercanidipine hydrochloride and process for their preparation. - Google Patents

Novel crystalline polymorphic forms of lercanidipine hydrochloride and process for their preparation. Download PDF

Info

Publication number
OA12648A
OA12648A OA1200400033A OA1200400033A OA12648A OA 12648 A OA12648 A OA 12648A OA 1200400033 A OA1200400033 A OA 1200400033A OA 1200400033 A OA1200400033 A OA 1200400033A OA 12648 A OA12648 A OA 12648A
Authority
OA
OAPI
Prior art keywords
lercanidipine
hydrochloride
lercanidipine hydrochloride
crude
solid
Prior art date
Application number
OA1200400033A
Other languages
English (en)
Inventor
Fausto Bonifacio
Itfrancesco Campana
Gianluca De Iasi
Amedeo Leonardi
Original Assignee
Recordati Ireland Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=11448245&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=OA12648(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Recordati Ireland Ltd filed Critical Recordati Ireland Ltd
Publication of OA12648A publication Critical patent/OA12648A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D211/00Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
    • C07D211/04Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D211/80Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
    • C07D211/84Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen directly attached to ring carbon atoms
    • C07D211/90Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • A61P9/12Antihypertensives

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
OA1200400033A 2001-08-06 2002-08-05 Novel crystalline polymorphic forms of lercanidipine hydrochloride and process for their preparation. OA12648A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT2001MI001726A ITMI20011726A1 (it) 2001-08-06 2001-08-06 Forme polimorfe della lercanidipina cloridrato

Publications (1)

Publication Number Publication Date
OA12648A true OA12648A (en) 2006-06-16

Family

ID=11448245

Family Applications (1)

Application Number Title Priority Date Filing Date
OA1200400033A OA12648A (en) 2001-08-06 2002-08-05 Novel crystalline polymorphic forms of lercanidipine hydrochloride and process for their preparation.

Country Status (36)

Country Link
EP (4) EP2036890A1 (es)
JP (1) JP2005504045A (es)
KR (3) KR100626819B1 (es)
CN (2) CN100448847C (es)
AP (1) AP1766A (es)
AR (1) AR037139A1 (es)
AT (2) ATE307114T1 (es)
AU (1) AU2002327924C1 (es)
BR (1) BR0211739A (es)
CY (2) CY1109711T1 (es)
DE (2) DE60206787T2 (es)
DK (3) DK2157083T3 (es)
EA (1) EA005673B1 (es)
EC (1) ECSP044973A (es)
ES (3) ES2212759T3 (es)
HK (3) HK1067123A1 (es)
HR (1) HRP20040156B1 (es)
HU (1) HU229563B1 (es)
IL (3) IL164648A0 (es)
IT (1) ITMI20011726A1 (es)
MA (1) MA27133A1 (es)
ME (2) MEP2908A (es)
MX (1) MXPA04001069A (es)
NO (2) NO325541B1 (es)
NZ (2) NZ541341A (es)
OA (1) OA12648A (es)
PE (1) PE20030328A1 (es)
PL (1) PL216066B1 (es)
PT (2) PT2157083E (es)
RS (1) RS52161B (es)
SI (3) SI1600441T1 (es)
TN (1) TNSN04024A1 (es)
UA (1) UA82988C2 (es)
UY (1) UY27410A1 (es)
WO (1) WO2003014084A1 (es)
ZA (1) ZA200401806B (es)

Families Citing this family (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITMI20011726A1 (it) 2001-08-06 2003-02-06 Recordati Ind Chimica E Farma Forme polimorfe della lercanidipina cloridrato
AR043395A1 (es) * 2003-02-28 2005-07-27 Recordati Ireland Ltd Terapia de combinacion para la hipertension utilizando lercanidipina y un bloqueante de los receptores de angiotensina ii
CA2547657A1 (en) * 2003-12-01 2005-06-16 Lifecycle Pharma A/S Pharmaceutical compositions comprising lercanidipine
AR052918A1 (es) 2005-02-25 2007-04-11 Recordati Ireland Ltd Clorhidrato de lercanidipina amorfo
KR20080048065A (ko) 2005-09-16 2008-05-30 그렌마크 파머수티칼스 엘티디. 다형 형태의 염산 레르카니디핀 및 이것의 제조방법
KR100821165B1 (ko) * 2006-03-10 2008-04-14 동우신테크 주식회사 레르카니디핀 염산염의 제조 방법
JP2010514753A (ja) * 2006-12-29 2010-05-06 ドンウ シンテック カンパニー リミテッド レルカニジピン塩酸塩の製造方法
EP2121575A2 (en) * 2007-03-05 2009-11-25 Actavis Group PTC EHF Lercanidipine hydrochloride polymorphs and an improved process for preparation of 1,1,n-trimethyl-n-(3,3-diphenylpropyl)-2-aminoethyl acetoacetate
WO2011161223A2 (en) 2010-06-23 2011-12-29 Krka, Tovarna Zdravil, D.D., Novo Mesto Pharmaceutical oral dosage forms comprising lercanidipine and enalapril and their pharmaceutically acceptable salts
EP2444394A1 (en) 2010-10-21 2012-04-25 Alembic Pharmaceuticals Limited Process for the preparation of amorphous form of lercanidipine HCI
EP2654729B1 (en) 2010-12-24 2016-05-04 KRKA, d.d., Novo mesto Homogenous pharmaceutical oral dosage forms comprising lercanidipine and enalapril or their pharmaceutically acceptable salts together with an organic acid
EP2700632A4 (en) * 2011-04-18 2014-09-03 Hefei Beini Medical Technology Company Ltd METHOD FOR CLEANING DIHYDROPYRIDINE CALCIUM CHANNEL BLOCKERS AND PRODUCING NANOPARTICLES THEREFOR
CN102558032B (zh) * 2011-12-16 2014-02-26 华润赛科药业有限责任公司 一种无定形盐酸乐卡地平及其制备方法
CN102531999B (zh) * 2011-12-16 2014-02-26 华润赛科药业有限责任公司 无定形盐酸乐卡地平及其制备方法
CN102584682A (zh) * 2011-12-31 2012-07-18 苏州二叶制药有限公司 盐酸乐卡地平的制备方法
CN103497075B (zh) * 2013-09-25 2016-03-23 山西北化关铝化工有限公司 水悬浮延期药造型粉
CN109232389B (zh) * 2018-05-15 2021-10-08 迪嘉药业集团有限公司 一种小粒度硝苯地平的结晶制备方法
CN115353485B (zh) * 2022-07-26 2024-04-19 山西双雁药业有限公司 从硝苯地平母液中回收硝苯地平的方法及应用
CN115671066A (zh) * 2022-11-21 2023-02-03 安徽宏业药业有限公司 一种盐酸乐卡地平缓释片及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US596139A (en) * 1897-12-28 Process of generating acetylene gas
GB8403866D0 (en) 1984-02-14 1984-03-21 Recordati Chem Pharm Diphenylalkylaminoalkyl esters
IT1274480B (it) * 1995-05-12 1997-07-17 Recordati Chem Pharm Procedimento migliorato per la preparazione della lercanidipina cloridrato
IT1275532B (it) * 1995-07-14 1997-08-07 Recordati Chem Pharm Uso di derivati 1,4-diidropiridinici per la prevenzione e la terapia della degenerazione aterosclerotica della parete arteriosa
US5696139A (en) 1995-05-12 1997-12-09 Recordati S.A., Chemical And Pharmaceutical Company Use of S-enantiomers of 1,4-dihydropyridine derivatives for treating heart failure
US5912351A (en) 1995-05-12 1999-06-15 Recordati, S.A. Chemical And Pharmaceutical Company Anhydrous 1,4-Dihydropyridines and salts thereof
US6995161B2 (en) 2000-02-16 2006-02-07 Neurogen Corporation Substituted arylpyrazines
ITMI20011726A1 (it) 2001-08-06 2003-02-06 Recordati Ind Chimica E Farma Forme polimorfe della lercanidipina cloridrato
US20040198789A1 (en) 2003-02-28 2004-10-07 Recordati Ireland Limited Lercanidipine/ARB/diuretic therapeutic combinations

Also Published As

Publication number Publication date
EP1432683A1 (en) 2004-06-30
ES2555213T3 (es) 2015-12-29
UA82988C2 (uk) 2008-06-10
EP1432683B1 (en) 2005-10-19
NO20040266L (no) 2004-03-24
KR20040030903A (ko) 2004-04-09
EP1600441A2 (en) 2005-11-30
EP2157083A3 (en) 2010-03-24
ATE307114T1 (de) 2005-11-15
SI1600441T1 (sl) 2010-02-26
IL164648A (en) 2007-02-11
ME01525B (me) 2011-02-10
AP1766A (en) 2007-08-10
ES2334678T3 (es) 2010-03-15
HUP0401163A2 (hu) 2004-09-28
DK2157083T3 (en) 2015-11-02
IL153917A0 (en) 2003-07-31
IL164648A0 (en) 2005-12-18
HRP20040156B1 (en) 2012-03-31
MXPA04001069A (es) 2005-02-17
SI2157083T1 (sl) 2016-01-29
HK1140487A1 (en) 2010-10-15
ZA200401806B (en) 2005-06-29
PL216066B1 (pl) 2014-02-28
DE60206787D1 (de) 2006-03-02
CY1109711T1 (el) 2014-08-13
KR20050111799A (ko) 2005-11-28
CN101475524A (zh) 2009-07-08
HU229563B1 (en) 2014-02-28
ES2212759T3 (es) 2006-04-16
ATE453624T1 (de) 2010-01-15
EA005673B1 (ru) 2005-04-28
RS52161B (en) 2012-08-31
MEP2908A (en) 2010-10-10
ITMI20011726A1 (it) 2003-02-06
EP2157083A2 (en) 2010-02-24
AR037139A1 (es) 2004-10-27
AP2004002989A0 (en) 2004-03-31
ECSP044973A (es) 2004-06-28
EA200400280A1 (ru) 2004-08-26
BR0211739A (pt) 2004-09-28
NO325541B1 (no) 2008-06-16
EP1432683B9 (en) 2006-01-18
UY27410A1 (es) 2003-03-31
KR100626819B1 (ko) 2006-09-20
EP1600441A3 (en) 2005-12-07
AU2002327924C1 (en) 2009-12-10
KR100667687B1 (ko) 2007-01-12
NO335651B1 (no) 2015-01-19
PT2157083E (pt) 2016-01-22
JP2005504045A (ja) 2005-02-10
HRP20040156A2 (en) 2004-08-31
WO2003014084A1 (en) 2003-02-20
DE60206787T2 (de) 2006-07-13
EP1600441B1 (en) 2009-12-30
HK1067123A1 (en) 2005-04-01
NZ531558A (en) 2005-12-23
AU2002327924B2 (en) 2008-04-24
PL369522A1 (en) 2005-05-02
NZ541341A (en) 2007-02-23
RS11304A (en) 2007-02-05
TNSN04024A1 (en) 2006-06-01
HUP0401163A3 (en) 2009-04-28
PE20030328A1 (es) 2003-05-09
SI1432683T1 (sl) 2006-04-30
PT1600441E (pt) 2010-01-20
CN100448847C (zh) 2009-01-07
EP2036890A1 (en) 2009-03-18
CN1538957A (zh) 2004-10-20
IL153917A (en) 2005-11-20
DK1432683T3 (da) 2006-03-06
DK1600441T3 (da) 2010-02-08
ITMI20011726A0 (it) 2001-08-06
KR20050043992A (ko) 2005-05-11
CN101475524B (zh) 2012-08-29
CY1117051T1 (el) 2017-04-05
HK1086263A1 (en) 2006-09-15
EP2157083B1 (en) 2015-09-30
MA27133A1 (fr) 2005-01-03
NO20082330L (no) 2004-03-24
ES2212759T1 (es) 2004-08-01
DE60234961D1 (de) 2010-02-11

Similar Documents

Publication Publication Date Title
US20050192323A1 (en) Novel crude and crystalline forms of lercanidipine hydrochloride
OA12648A (en) Novel crystalline polymorphic forms of lercanidipine hydrochloride and process for their preparation.
EP1799644B1 (en) Lercanidipine salts
AU2002327924A1 (en) Novel crystalline polymorphic forms of lercanidipine hydrochloride and process for their preparation
US20030069285A1 (en) Novel solvate and crystalline forms of lercanidipine hydrochloride
KR100912664B1 (ko) 레르카니디핀 염산의 용매화물 및 레르카니디핀 염산의신규 결정형
AU2002331390A1 (en) Solvates of lercanidipine hydrochloride and new crystalline forms of lercanidipine hydrochloride
CA2399459C (en) Novel crude and crystalline forms of lercanidipine hydrochloride
CA2380202A1 (en) Novel crude and crystalline forms of lercanidipine hydrochloride